Best Medical Device Development Companies

Zühlke vs Veranex: full comparison for 2026

Quick verdict

Zühlke (4.4/5) edges ahead of Veranex (4.2/5) overall. Zühlke is the better choice for european medtech firms modernizing device software. Veranex is the stronger option for device design plus clinical trials and reimbursement. The right choice depends on your project size, budget, and required tech stack.

Zühlke vs Veranex: head-to-head summary

Criterion Zühlke Veranex
Founded 1968 2021
HQ Schlieren, Switzerland Raleigh, NC, USA
Team size 1,500–2,000 800+
Rating 4.4 / 5 4.2 / 5
Primary differentiator A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program One contract can cover engineering, clinical studies, regulatory strategy and reimbursement
Pricing model Time and materials, fixed project Fixed project, time and materials
Min. engagement Not disclosed Not disclosed
Primary tech stack Embedded C/C++, Embedded Linux, Cloud (AWS/Azure) ISO 13485 QMS, SolidWorks, Embedded C/C++
Industries served Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health

Zühlke vs Veranex: overview

Zühlke

Partner-owned since its 1968 founding in Switzerland, Zühlke is headquartered in Schlieren near Zurich, with teams in Germany, Austria, the UK, Serbia and Asia. Its headcount is somewhere between 1,500 and 2,000 depending on the source. In healthcare it covers regulated device and systems engineering, connected-device software and the cloud and analytics platforms around devices, and it states more than 50 years of medtech experience (per company website; independently unverifiable).

Veranex

Veranex was formed in 2021 by Summit Partners, which combined Providence-based device developer Ximedica (founded 1985) with Quartesian and Boston Healthcare Associates. It has since acquired Experien Group, IMM Recherche, the healthcare design firm Worrell, Fusion Biotec and Horus Scientific. Headquartered in Raleigh, North Carolina, it reports more than 800 staff and offers product design and engineering, clinical research (CRO) services, regulatory work and market access consulting.

Services and capabilities: Zühlke vs Veranex

Capability Zühlke Veranex
Electronics & PCB design ✓ ✓
Firmware & embedded software ✓ ✗
SaMD & companion apps ✓ ✗
Connected devices & IoT ✓ ✗
Industrial design & human factors ✗ ✓
Mechanical engineering ✗ ✓
Device cybersecurity ✗ ✗
Regulatory & QMS support ✓ ✓
Manufacturing & scale-up ✗ ✗

Tech stack comparison: Zühlke vs Veranex

Framework / platform Zühlke Veranex
Embedded C/C++ ✓ ✓
Embedded Linux ✓ N/A
RTOS N/A N/A
BLE N/A N/A
Cloud (AWS/Azure) ✓ N/A
IEC 62304 ✓ N/A
ISO 14971 N/A N/A
ISO 13485 QMS N/A ✓
Qt ✓ N/A

Pricing comparison: Zühlke vs Veranex

Criterion Zühlke Veranex
Minimum engagement Not disclosed Not disclosed
Engagement models Consulting, Dedicated team, Fixed project, Time & materials Consulting, Fixed project, Time & materials
Rate transparency Not public Not public
Price tier Mid-market Mid-market

Target audience comparison: Zühlke vs Veranex

Dimension Zühlke Veranex
Best company size Startup to mid-market Startup to mid-market
Best industries Digital health, Diagnostics & lab devices, Surgical & therapeutic devices Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery
Best use cases Rebuilding the embedded and cloud software of an established diagnostics platform, EU MDR remediation of legacy device software Startup that needs design, a clinical study and an FDA strategy from one partner, Human-centered redesign of a surgical instrument
Typical project type Consulting Consulting

Zühlke vs Veranex: pros and cons

Zühlke
+ Partner ownership keeps the firm independent of a large holding group
+ Large enough to staff hardware, embedded, cloud and data roles at the same time
+ Delivery centres in Serbia and Asia give some cost flexibility compared with all-Swiss teams
+ Experience with EU MDR environments in German-speaking markets
- Much of the firm works outside healthcare, so check that the proposed team is from the medtech practice
- Swiss and German rates are high for the onshore part of a team
- Industrial design and manufacturing are not core offerings
Veranex
+ Rare combination of engineering with CRO, regulatory and market access services
+ Ximedica brings decades of ISO 13485 device development experience
+ Worrell adds human-centered design for healthcare
+ Large enough to run several workstreams at once
- Built from many acquisitions since 2021, so teams and processes are still being joined up
- Private-equity ownership by Summit Partners
- Buyers who only need engineering may pay for a broader structure than they use

Who should choose Zühlke?

A typical fit: rebuilding the embedded and cloud software of an established diagnostics platform.

A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services.

Who should choose Veranex?

A typical fit: startup that needs design, a clinical study and an FDA strategy from one partner.

One contract can cover engineering, clinical studies, regulatory strategy and reimbursement. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health.

Decision matrix: Zühlke vs Veranex

Your situation Recommended choice
You need full-ownership delivery on a defined project scope Zühlke
You need a large dedicated team for an ongoing programme Zühlke
Your budget is at the lower end Compare: Zühlke (Not disclosed) vs Veranex (Not disclosed)
You need specialist depth in a specific vertical Zühlke
You need staff augmentation or team extension Neither; consider alternatives that offer staff aug
You need consulting before committing to a build Both may offer discovery engagements

Use case fit: Zühlke vs Veranex

Use case Zühlke fit Veranex fit Winner
Rebuilding the embedded and cloud software of an established diagnostics platform Strong Limited Zühlke
EU MDR remediation of legacy device software Strong Limited Zühlke
Startup that needs design, a clinical study and an FDA strategy from one partner Limited Strong Veranex
Human-centered redesign of a surgical instrument Limited Strong Veranex

Verdict: Zühlke vs Veranex

Zühlke (4.4/5) is the stronger overall choice for most Medical Device Development projects. A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program.

Veranex (4.2/5) is worth a look if you need human-centered redesign of a surgical instrument. If your situation matches that, Veranex is a competitive option.

Related comparisons

Zühlke vs Veranex FAQ

Is Zühlke better than Veranex?

Zühlke (4.4/5) scores higher overall, but "better" depends on your use case. Zühlke's strongest advantage: partner ownership keeps the firm independent of a large holding group. Veranex's strongest advantage: rare combination of engineering with CRO, regulatory and market access services.

How do Zühlke and Veranex differ in pricing?

Zühlke uses time and materials, fixed project pricing. Veranex uses fixed project, time and materials pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.

Which is better for enterprise: Zühlke or Veranex?

Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.

What are the main differences between Zühlke and Veranex?

Zühlke's primary differentiator is: a device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Veranex's primary differentiator is: one contract can cover engineering, clinical studies, regulatory strategy and reimbursement. They also differ in team size (1,500–2,000 vs 800+), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Digital health, Diagnostics & lab devices vs Surgical & therapeutic devices, Diagnostics & lab devices).

Verify all details directly with each company before making a decision.